全文获取类型
收费全文 | 85794篇 |
免费 | 6677篇 |
国内免费 | 271篇 |
专业分类
耳鼻咽喉 | 957篇 |
儿科学 | 2205篇 |
妇产科学 | 1288篇 |
基础医学 | 11795篇 |
口腔科学 | 946篇 |
临床医学 | 9276篇 |
内科学 | 18224篇 |
皮肤病学 | 966篇 |
神经病学 | 8289篇 |
特种医学 | 3340篇 |
外科学 | 13720篇 |
综合类 | 1071篇 |
一般理论 | 93篇 |
预防医学 | 6699篇 |
眼科学 | 1983篇 |
药学 | 5877篇 |
中国医学 | 95篇 |
肿瘤学 | 5918篇 |
出版年
2023年 | 634篇 |
2022年 | 414篇 |
2021年 | 2463篇 |
2020年 | 1430篇 |
2019年 | 2303篇 |
2018年 | 2644篇 |
2017年 | 1910篇 |
2016年 | 1976篇 |
2015年 | 2324篇 |
2014年 | 3368篇 |
2013年 | 4300篇 |
2012年 | 6866篇 |
2011年 | 7144篇 |
2010年 | 3881篇 |
2009年 | 3399篇 |
2008年 | 5721篇 |
2007年 | 5877篇 |
2006年 | 5473篇 |
2005年 | 5414篇 |
2004年 | 4950篇 |
2003年 | 4545篇 |
2002年 | 4117篇 |
2001年 | 889篇 |
2000年 | 667篇 |
1999年 | 819篇 |
1998年 | 875篇 |
1997年 | 667篇 |
1996年 | 549篇 |
1995年 | 499篇 |
1994年 | 464篇 |
1993年 | 448篇 |
1992年 | 445篇 |
1991年 | 390篇 |
1990年 | 384篇 |
1989年 | 317篇 |
1988年 | 290篇 |
1987年 | 261篇 |
1986年 | 272篇 |
1985年 | 275篇 |
1984年 | 289篇 |
1983年 | 229篇 |
1982年 | 296篇 |
1981年 | 272篇 |
1980年 | 195篇 |
1979年 | 171篇 |
1978年 | 171篇 |
1977年 | 143篇 |
1976年 | 110篇 |
1975年 | 101篇 |
1974年 | 114篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
4.
Triposkiadis Filippos Xanthopoulos Andrew Skoularigis John Starling Randall C. 《Heart failure reviews》2022,27(6):1991-2003
Heart Failure Reviews - The nitric oxide (NO)–guanylate cyclase (GC)–cyclic guanosine monophosphate (cGMP) pathway plays an important role in cardiovascular, pulmonary and renal... 相似文献
5.
Joshua J. Bear Heidi E. Kirsch Brian D. Berman Kevin E. Chapman Jason R. Tregellas 《Epileptic Disord》2020,22(3):291-299
Aims. Functional connectivity is providing new insights into the network nature of epilepsy with growing clinical applications. Our objective was to validate a novel magnetoencephalography‐based method to non‐invasively measure the epileptic network. Methods. We retrospectively identified pediatric and adult patients with refractory focal epilepsy who underwent pre‐surgical magnetoencephalography with subsequent intracranial electrographic monitoring. Magnetoencephalography tracings were visually reviewed, and interictal epileptiform discharges (“spikes”) were individually marked. We then evaluated differences in whole‐brain connectivity during brief epochs preceding the spikes and during the spikes using the Network‐Based Statistic to test differences at the network level. Results. In six patients with statistically‐significant network differences, we observed substantial overlap between the spike‐associated networks and electrographically active areas identified during intracranial monitoring (the spike‐associated network was 78% and 83% sensitive for intracranial electroencephalography‐defined regions in the irritative and seizure onset zones, respectively). Conclusion. These findings support the neurobiological validity of the spike‐associated network method. Assessment of spike‐associated networks has the potential to improve surgical planning in epilepsy surgery patients by identifying components of the epileptic network prior to implantation. 相似文献
6.
Rupa Narayan MD Traci M. Blonquist MS Ashkan Emadi MD PhD Robert P. Hasserjian MD Meghan Burke BS Christopher Lescinskas BS Donna S. Neuberg ScD Andrew M. Brunner MD Gabriela Hobbs MD Hanno Hock MD PhD Steven L. McAfee MD Yi-Bin Chen MD Eyal Attar MD Timothy A. Graubert MD Christina Bertoli MSN Jenna A. Moran MSN Meghan K. Bergeron MSN Julia E. Foster MSN Aura Y. Ramos BSN Tina T. Som BSN Megan K. Vartanian BSN RN Jennifer L. Story LPN Kristin McGregor MS Molly Macrae BS Tanya Behnan BS Margaret C. Wey PhD Jessica Rae BSN Frederic I. Preffer PhD Patricia Lesho BA Vu H. Duong MD Mason L. Mann BA Karen K. Ballen MD Christine Connolly BS Philip C. Amrein MD Amir T. Fathi MD 《Cancer》2020,126(6):1264-1273
7.
8.
Xin Yi Wong Andrew Qi Jun Lim Qianyu Shen John Whay Kuang Chia Min Hoe Chew Wah Siew Tan 《Current medical research and opinion》2020,36(10):1677-1686
Abstract
Objective
Ras wild-type metastatic colorectal cancers (mCRC) may be treated with anti-vascular endothelial growth factor (VEGF) or anti-epidermal growth factor receptor (EGFR) agents. We aim to estimate patients’ preferences for mCRC treatment and relative importance of cost, efficacy improvement, avoidance of side effects and therapy convenience, and relative uptake between profiles that resemble Bevacizumab (anti-VEGF) and Cetuximab (anti-EGFR), two commonly prescribed mCRC targeted therapies. 相似文献9.